151.70 USD
↘ 3.16 (2.04%)AT CLOSE (03:59 PM EST)
Guardant Health, Inc. Common Stock
GHNASDAQ • USD
148.16
↘ 3.54 (2.33%)
POST MARKET (AS OF 04:15 PM EST)
Post Market
AS OF 04:15 PM EST
148.16
↘ 3.54 (2.33%)
Market: CLOSED
Shares of Guardant Health, Inc. Common Stock (GH) are trading at $151.70. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a robust Altman Z-Score, exceptional Return on Equity (175.8%) and a bullish Golden Cross on the moving averages. On the valuation front, GH trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.
Technical & fundamental data as of Nov 13, 2026.
Open?$156.02
High?$156.02
Low?$148.01
Prev. Close?$154.86
Volume?1.3M
Avg. Volume?2.1M
VWAP?$151.76
Rel. Volume?0.61x
Bid / Ask
Bid?$135.00 × 100
Ask?$162.00 × 1.0K
Spread?$27.00
Midpoint?$148.50
Valuation & Ratios
Market Cap?20.5B
Shares Out?135.3M
Float?127.0M
Float %?94.6%
P/E Ratio?N/A
P/B Ratio?-74.38
EPS?-$3.59
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
Themes
Employees
2.5K
Market Cap
20.5B
Industry
SERVICES-MEDICAL LABORATORIES
Website
Listed
2018-10-04
Address
3100 HANOVER STREET
PALO ALTO, CA 94304
Phone: 855-698-8887
PALO ALTO, CA 94304
Phone: 855-698-8887
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?40
Z-Score?99
Momentum?83
Short Sent.?50
Piotroski F-Score?4/9Mixed
Altman Z-Score?5.75Safe
Confidence?66%Moderate
Short InterestHigh
Short % of Float?7.43%Elevated
Short Interest?9.4M
Days to Cover?5.4
Free Float127.0M
Avg Daily Volume1.8M
Settlement Date2026-10-30
Financial Health
Current Ratio?3.60Strong
Quick Ratio?3.35Strong
Cash Ratio?2.75Strong
Debt/Equity?-5.45Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?-74.38CHEAP▾
S&P97
P/S?16.05HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-45.2CHEAP▾
S&P97
EV/Sales?16.42HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?175.8%STRONG▾
Peers50
S&P97
ROA?-25.7%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-232148000
Enterprise Value?$21.0B
Fundamentals ratios updated end of day